The Menopause After Cancer Study

PHASE2CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

June 21, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
MenopauseCancerInsomnia
Interventions
COMBINATION_PRODUCT

Citalopram +/- Gabapentin + Sleepio + support person

All participants will receive citalopram and/or gabapentin to manage vasomotor symptoms of menopause and will get access to digital CBT for insomnia and be asked to identify a support person

Trial Locations (2)

Unknown

Mater Misericordiae University Hospital, Dublin

St. Vincent's University Hospital, Dublin

All Listed Sponsors
collaborator

Irish Cancer Society

OTHER

collaborator

Big Health Inc.

INDUSTRY

collaborator

myPatientSpace

UNKNOWN

lead

University College Dublin

OTHER